LYKA LABORATORIESLYKA LABORATORIESLYKA LABORATORIES

LYKA LABORATORIES

No trades
See on Supercharts
Market capitalization
‪4.15 B‬INR
−1.15INR
‪−132.12 M‬INR
‪916.90 M‬INR
‪15.04 M‬
Beta (1Y)
−0.04

About LYKA LABORATORIES

CEO
Kunal Narendra Gandhi
Headquarters
Mumbai
Employees (FY)
296
Founded
1976
ISIN
INE933A01014
FIGI
BBG000CVSRN2
Lyka Labs Ltd. is a holding company, which engages in the manufacture of pharmaceutical formulations and active pharmaceutical ingredients. Its products include dry powder, liquid and lyophilised injections, and external preparations and cosmetics covering various therapeutic areas. The company was founded on December 29, 1976 and is headquartered in Mumbai, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of LYKALABS is 128.80 INR — it has increased by 2.43% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange LYKA LABORATORIES stocks are traded under the ticker LYKALABS.
LYKALABS stock is 7.09% volatile and has beta coefficient of −0.04. Check out the list of the most volatile stocks — is LYKA LABORATORIES there?
Yes, you can track LYKA LABORATORIES financials in yearly and quarterly reports right on TradingView.
LYKALABS stock has fallen by 1.53% compared to the previous week, the month change is a 17.04% rise, over the last year LYKA LABORATORIES has showed a 14.90% increase.
LYKALABS net income for the last quarter is ‪17.81 M‬ INR, while the quarter before that showed ‪−4.87 M‬ INR of net income which accounts for 466.08% change. Track more LYKA LABORATORIES financial stats to get the full picture.
Today LYKA LABORATORIES has the market capitalization of ‪4.15 B‬, it has increased by 10.98% over the last week.
No, LYKALABS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, LYKALABS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LYKA LABORATORIES stock right from TradingView charts — choose your broker and connect to your account.
LYKALABS reached its all-time high on Dec 24, 2021 with the price of 267.00 INR, and its all-time low was 8.15 INR and was reached on Dec 21, 2011.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 296.00 employees. See our rating of the largest employees — is LYKA LABORATORIES on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LYKA LABORATORIES technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LYKA LABORATORIES stock shows the buy signal. See more of LYKA LABORATORIES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LYKA LABORATORIES EBITDA is ‪168.74 M‬ INR, and current EBITDA margin is 17.19%. See more stats in LYKA LABORATORIES financial statements.